From Protocol to Practice: Precision and Accountability at Every Milestone
Southern Star Research provides end-to-end clinical trial operational services, specializing in study design, rapid startup via Australia’s regulatory pathways, and senior-led clinical management.
Protocol Interrogation & De-risking
A protocol that is scientifically sound on paper can often encounter friction in a real-world clinical setting. We engage in a multi-disciplinary review, involving active medical monitors and former Principal Investigators, to ensure your study is operationally executable.
We review inclusion criteria and participant flow through a “site-eye view” to identify potential recruitment barriers before they impact study conduct.
Our goal is to identify and resolve study design challenges early, ensuring the protocol is optimized for both regulatory approval and high-quality data generation.
Strategic Foresight, Not Just Filings
We leverage the CTN scheme and our deep familiarity with Human Research Ethics Committees (HREC) to compress the activation window.
We navigate the regulatory pathway with a bias for action, aiming to move from dossier to execution weeks ahead of global averages.
We act as your peer-level bridge, translating regional nuances into a clear, predictable roadmap for your board and investors.
Ownership that Drives Study Velocity
Our clinical operations teams are senior-heavy by design: therapeutically matched to your protocol, with the site-level relationships and clinical judgment to keep your study on trajectory before issues surface.
Our reputation for expert study management means many high-performing sites prioritize Southern Star Research trials, ensuring your program remains front-of-mind for investigators.
Our CRAs are therapeutically matched to your protocol, ensuring meticulous oversight of data entry and patient safety throughout the trial lifecycle.
We provide comprehensive project management from initiation through to study close-out, ensuring continuity of communication and protocol adherence.
Investor-Grade Data Integrity
Your clinical data is the foundation of your commercial future. We provide a full suite of biometrics services ensuring compliance with ICH-GCP and CDISC standards.
We deliver clean, robust data packages that meet the exacting standards of the FDA, EMA, PMDA, and Health Canada.
Our systems provide the high-fidelity metrics needed to demonstrate progress and maintain stakeholder confidence.
Active Medical Stewardship
Safety is an intellectual engagement, not a passive reporting function. Our medical monitoring provides constant, peer-level clinical oversight.
Our monitors (experienced physicians) are directly available to site investigators for real-time eligibility and safety queries.
We utilize validated safety systems, including Argus, to ensure global compliance for adverse event reporting and signal detection.
Monitors engage in proactive safety trend analysis and attend investigator meetings to protect participant welfare and asset integrity.
Communicating Science with Clarity
We translate complex data into clear, compliant documentation that stands up to global regulatory scrutiny.
Our team ensures every document, from Investigator Brochures to Clinical Study Reports, meets ICH-E3 and ICH-E6 (GCP) standards.
Our expertise includes protocols, Informed Consent Forms (ICFs), safety narratives, and the preparation of abstracts and manuscripts for peer-reviewed journals.
Methodological Forethought
We define quality not by post-trial inspection, but by the application of rigorous clinical judgment during the planning phase.
Our QA teams ensure every facet of your trial is “audit-ready” from the first patient screened to the final database lock.
We maintain a robust Quality Management System (QMS) that adapts to sponsor-specific SOPs while ensuring absolute adherence to international regulatory standards.
A full technical specifications for Biometrics, Safety, and Regulatory affairs to share with your clinical operations team.
